Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PANG.MC
- Price
- 1.68
- Stock movement up
- +- (%)
- Company name
- Pangaea Oncology S.A.
- Exchange
- (MC ,
- Currency
- EUR )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 57.24M
- Ent value
- 65.88M
- Price/Sales
- 13.10
- Price/Book
- 3.04
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -5.62%
- 3 year return
- -3.55%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
PANG.MC does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 13.10 |
| Price to Book | 3.04 |
| EV to Sales | 15.08 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 34.07M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.37M |
| Gross profit (TTM) | 2.17M |
| Operating income (TTM) | -2.51M |
| Net income (TTM) | -2.71M |
| EPS (TTM) | - |
| EPS (1y forward) | -0.03 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 49.79% |
| Operating margin (TTM) | -57.58% |
| Profit margin (TTM) | -62.09% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.38M |
| Net receivables | 5.67M |
| Total current assets | 9.63M |
| Goodwill | 3.78M |
| Intangible assets | 12.13M |
| Property, plant and equipment | 0.00 |
| Total assets | 28.83M |
| Accounts payable | 2.33M |
| Short/Current long term debt | 5.73M |
| Total current liabilities | 7.17M |
| Total liabilities | 10.03M |
| Shareholder's equity | 18.81M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.84M |
| Capital expenditures (TTM) | 20.09K |
| Free cash flow (TTM) | -4.86M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -14.42% |
| Return on Assets | -9.41% |
| Return on Invested Capital | -11.96% |
| Cash Return on Invested Capital | -21.45% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.68 |
| Daily high | 1.68 |
| Daily low | 1.68 |
| Daily Volume | 0K |
| All-time high | 3.07 |
| 1y analyst estimate | - |
| Beta | 0.07 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PANG.MC | S&P500 | |
| Current price drop from All-time high | -45.24% | -12.89% |
| Highest price drop | -68.84% | -56.47% |
| Date of highest drop | 11 Aug 2020 | 9 Mar 2009 |
| Avg drop from high | -40.85% | -11.07% |
| Avg time to new high | 301 days | 12 days |
| Max time to new high | 1200 days | 1805 days |
COMPANY DETAILS
Marketcap
57.24M
Marketcap category
Small-cap
Description
Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. It also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development. Pangaea Oncology, S.A. was founded in 2006 and is based in Barcelona, Spain.
Employees
149
Website
Investor relations
-
SEC filings
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found